Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) are up big today, after the company reported their fourth quarter and full-year revenue and earnings. They reported a net income of $4.6 million for the quarter which is much better than last year when they reported a net loss. This equated to $0.08 per share.
For the full-year, OraSure Technologies, Inc. (NASDAQ:OSUR) reported net income of $8.2 million which is approximately $0.14 per share. It was the first time the company showed a profit in 8 years. Additionally, the company also released their forward looking guidance. They expect EPS to come in at between $0.01 and $0.02 per share, beating Wall Street’s estimate of $0.01 slightly. They also reported revenue guidance of between $28.5 million and $29 million, which met analysts’ estimates of $28.97 million.
The stock is up 18.91% or $1.04 following the news, hitting $6.54 per share. About 1.44M shares traded hands or up 197.19% from the average. OSUR has risen 2.04% since June 30, 2015 and is currently uptrending. It has outperformed the S&P500 by 9.34%.
From a total of 2 analysts covering OraSure Technologies (NASDAQ:OSUR) stock, 2 rate it a “Buy”, 0 a “Sell”, and 0 a “Hold”. This means that 100% of the ratings are positive. The highest target price is $9 while the lowest target price is $8. The mean of all analyst targets is $8 which is 22.32% above today’s ($6.54) stock price. OraSure Technologies was the topic of 4 analyst reports since August 6, 2015 according to the firm StockzIntelligence Inc. Mizuho maintained shares on November 5 with a “Buy” rating.
The institutional sentiment increased to 1.29 in Q2 2015. It’s up 0.71, from 0.58 in 2015Q2. The ratio improved, as 9 funds sold all their OraSure Technologies, Inc. shares they owned while 43 reduced their positions. 18 funds bought stakes while 49 increased their total positions. Institutions now own 36.80 million shares which is 2.38% less than the previous share count of 37.70 million in 2015Q2.
Domini Social Investments Llc holds 7.78% of its total portfolio in OraSure Technologies, Inc., equating to 107,254 shares. Camber Capital Management Llc owns 2.00 million shares representing 0.76% of their total US portfolio. Moreover, Healthinvest Partners Ab has 0.73% of their total portfolio invested in the company, equating to 276,603 shares. The New York-based Rtw Investments Llc has a total of 0.45% of their portfolio invested in the stock. Rotella Capital Management Inc., a Washington-based fund reported 274,033 shares owned.
OraSure Technologies, Inc. is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. The company has a market cap of $310.42 million. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. It has 425.78 P/E ratio. Saliva Alcohol test.